Medicine
Atracurium 50 mg/5 mL injection
Atracurium 50 mg/5 mL injection is a generic prescription medicine for intravenous use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Upon removal from refrigeration to room temperature storage conditions…
Key facts
- Active ingredient (INN)
- Atracurium
- Brand
- Sold under the generic name
- Strength
- 50 mg/5 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 10 vials of 5 mL
- Manufacturers
- AuroMedics PharmaIndiaHospiraMeitheal Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Upon removal from refrigeration to room temperature storage conditions (25°C/77°F), use Atracurium Besylate Injection within 14 days even if re-refrigerated. Do not freeze. Store between 2° and 8°C (36° and 46°F) to preserve potency. Protect from light.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 February 2013
- Identifiers
- RxCUI 966768, 1718913DailyMed set ID efe90ee2-fe9e-421f-9e54-2961085d3b12, 71d4bc78-57df-474b-8b19-811a959f1fce, de1c2dcd-295b-47ce-b7a1-a8be59939a54NDC 71288-701, 55150-216, 0409-1109Application ANDA091488, ANDA206010, ANDA090782
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-use in 1 carton / 5 mL in 1 vial, single-use | 55150-216-05 | AuroMedics PharmaIndia | 8 April 2015 |
| 10 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 0409-1109-01 | Hospira | 25 February 2013 |
| 10 vial, single-dose in 1 carton / 5 mL in 1 vial, single-dose | 71288-701-05 | Meitheal Pharmaceuticals | 15 May 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 November 1983 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Atracurium
Clinical summary
Atracurium is a nondepolarizing neuromuscular blocker indicated , as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is available as injection for intravenous use. MedsAcross supplies Atracurium for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AtracuriumFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Atracurium Besylate prescribing information (Meitheal Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Atracurium 50 mg/5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.